BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2414666)

  • 1. Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line.
    Roberts A; Perera S; Lang B; Vincent A; Newsom-Davis J
    Nature; 1985 Oct 24-30; 317(6039):737-9. PubMed ID: 2414666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Springer Semin Immunopathol; 1985; 8(1-2):129-40. PubMed ID: 2988146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels.
    Hewett SJ; Atchison WD
    Brain Res; 1992 Dec; 599(2):324-32. PubMed ID: 1363289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lambert-Eaton myasthenic syndrome: a review.
    Newsom-Davis J
    Monogr Allergy; 1988; 25():116-24. PubMed ID: 2845259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies omega-conotoxin and adenosine.
    De Aizpurua HJ; Lambert EH; Griesmann GE; Olivera BM; Lennon VA
    Cancer Res; 1988 Sep; 48(17):4719-24. PubMed ID: 2457429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder.
    Vincent A; Lang B; Newsom-Davis J
    Trends Neurosci; 1989 Dec; 12(12):496-502. PubMed ID: 2480664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse.
    Lang B; Newsom-Davis J; Peers C; Prior C; Wray DW
    J Physiol; 1987 Sep; 390():257-70. PubMed ID: 2450991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals.
    Prior C; Lang B; Wray D; Newsom-Davis J
    Ann Neurol; 1985 Jun; 17(6):587-92. PubMed ID: 2992356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of synaptosomal calcium channel function by Lambert-Eaton myasthenic immunoglobulin is serum-dependent.
    Hewett SJ; Atchison WD
    Brain Res; 1992 Dec; 599(2):317-23. PubMed ID: 1363288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and plasma from patients with Lambert-Eaton Myasthenic Syndrome reduce depolarization-dependent uptake of 45Ca2+ into rat cortical synaptosomes.
    Hewett SJ; Atchison WD
    Brain Res; 1991 Dec; 566(1-2):320-4. PubMed ID: 1814548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction.
    Peers C; Johnston I; Lang B; Wray D
    Neurosci Lett; 1993 Apr; 153(1):45-8. PubMed ID: 8390031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lambert-Eaton myasthenic syndrome: immunoglobulin G inhibition of Ca2+ flux in tumor cells correlates with disease severity.
    Lang B; Vincent A; Murray NM; Newsom-Davis J
    Ann Neurol; 1989 Mar; 25(3):265-71. PubMed ID: 2543262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line.
    Peers C; Lang B; Newsom-Davis J; Wray DW
    J Physiol; 1990 Feb; 421():293-308. PubMed ID: 2161458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels.
    Kim YI; Neher E
    Science; 1988 Jan; 239(4838):405-8. PubMed ID: 2447652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones.
    Fukunaga H; Engel AG; Lang B; Newsom-Davis J; Vincent A
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7636-40. PubMed ID: 6584877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
    Takamori M
    J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
    Johnston I; Lang B; Leys K; Newsom-Davis J
    Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation.
    Nagel A; Engel AG; Lang B; Newsom-Davis J; Fukuoka T
    Ann Neurol; 1988 Oct; 24(4):552-8. PubMed ID: 2853605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells.
    Viglione MP; O'Shaughnessy TJ; Kim YI
    J Physiol; 1995 Oct; 488 ( Pt 2)(Pt 2):303-17. PubMed ID: 8568672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.
    Flink MT; Atchison WD
    J Physiol; 2002 Sep; 543(Pt 2):567-76. PubMed ID: 12205190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.